These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Comparison of anticoagulant effects of regulatory proline-containing oligopeptides. Specificity of glyprolines, semax, and selank and potential of their practical application]. Liapina LA; Pastorova VE; Obergan TIu; Samonina GE; Ashmarin IP; Miasoedov NF Izv Akad Nauk Ser Biol; 2006; (2):193-203. PubMed ID: 16634437 [TBL] [Abstract][Full Text] [Related]
7. Comparative study of modulatory effects of Semax and primary proline-containing peptides on hemostatic reactions. Cherkasova KA; Lyapina LA; Ashmarin IP Bull Exp Biol Med; 2001 Jul; 132(1):625-6. PubMed ID: 11687836 [TBL] [Abstract][Full Text] [Related]
8. Effects of semax and its Pro-Gly-Pro fragment on calcium homeostasis of neurons and their survival under conditions of glutamate toxicity. Storozhevykh TP; Tukhbatova GR; Senilova YE; Pinelis VG; Andreeva LA; Myasoyedov NF Bull Exp Biol Med; 2007 May; 143(5):601-4. PubMed ID: 18239779 [TBL] [Abstract][Full Text] [Related]
9. Effect of semax and its C-terminal fragment Pro-Gly-Pro on the expression of VEGF family genes and their receptors in experimental focal ischemia of the rat brain. Medvedeva EV; Dmitrieva VG; Povarova OV; Limborska SA; Skvortsova VI; Myasoedov NF; Dergunova LV J Mol Neurosci; 2013 Feb; 49(2):328-33. PubMed ID: 22772900 [TBL] [Abstract][Full Text] [Related]
10. Influence of the N-terminus acetylation of Semax, a synthetic analog of ACTH(4-10), on copper(II) and zinc(II) coordination and biological properties. Magrì A; Tabbì G; Giuffrida A; Pappalardo G; Satriano C; Naletova I; Nicoletti VG; Attanasio F J Inorg Biochem; 2016 Nov; 164():59-69. PubMed ID: 27586814 [TBL] [Abstract][Full Text] [Related]
11. Effects of behaviorally active ACTH (4-10) analogue - Semax on rat basal forebrain cholinergic neurons. Grivennikov IA; Dolotov OV; Zolotarev YA; Andreeva LA; Myasoedov NF; Leacher L; Black IB; Dreyfus CF Restor Neurol Neurosci; 2008; 26(1):35-43. PubMed ID: 18431004 [TBL] [Abstract][Full Text] [Related]
12. [Effect of new peptide bioregulators livagen and epitalon on enkephalin-degrading enzymes in human serum]. Kost NV; Sokolov OIu; Gabaeva MV; Zolotarev IuA; Malinin VV; Khavinson VKh Izv Akad Nauk Ser Biol; 2003; (4):427-9. PubMed ID: 12942748 [TBL] [Abstract][Full Text] [Related]
13. Degradation of ACTH/MSH(4-10) and its synthetic analog semax by rat serum enzymes: an inhibitor study. Potaman VN; Alfeeva LY; Kamensky AA; Nezavibatko VN Peptides; 1993; 14(3):491-5. PubMed ID: 8392718 [TBL] [Abstract][Full Text] [Related]
14. [Proteolysis of semax analogues with different N-terminal amino acids by aminopeptidases]. Shevchenko KV; V'iunova TV; Nagaev IIu; Andreeva LA; Alfeeva LIu; Miasoedov NF Bioorg Khim; 2011; 37(4):475-82. PubMed ID: 22096989 [TBL] [Abstract][Full Text] [Related]
15. The effect of Semax and its C-end peptide PGP on the morphology and proliferative activity of rat brain cells during experimental ischemia: a pilot study. Stavchansky VV; Yuzhakov VV; Botsina AY; Skvortsova VI; Bondurko LN; Tsyganova MG; Limborska SA; Myasoedov NF; Dergunova LV J Mol Neurosci; 2011 Oct; 45(2):177-85. PubMed ID: 20617398 [TBL] [Abstract][Full Text] [Related]
16. The peptide semax affects the expression of genes related to the immune and vascular systems in rat brain focal ischemia: genome-wide transcriptional analysis. Medvedeva EV; Dmitrieva VG; Povarova OV; Limborska SA; Skvortsova VI; Myasoedov NF; Dergunova LV BMC Genomics; 2014 Mar; 15():228. PubMed ID: 24661604 [TBL] [Abstract][Full Text] [Related]